A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-hodgkin lymphoma

Cancer Prevention Research

Volumn 6, Issue 8, 2013, Pages 864-873

  Bertrand, Kimberly A ^a,b   Giovannucci, Edward ^a,b   Zhang, Shumin M ^c   Laden, Francine ^a,b   Rosner, Bernard ^a,b   Birmann, Brenda M ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; BODY MASS; BODY SIZE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CHILD; CHILDHOOD; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SOMATOTYPE;

EID: 84883794946     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0132     Document Type: Article

References (50)

1. Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992;52(19 Suppl):5566s-9s.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER cancer statistics review, 1975-2009 (Vintage 2009 populations). Bethesda, MD: National Cancer Institute; 2009.
3. Ogden CL, Carroll MD. Prevalence of overweight, obesity, and extreme obesity among adults: United States, Trends 1960- 1962 through 2007-2008. Hyattsville, MD: National Center for Health Statistics; 2010.
4. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83. (Pubitemid 44453463)
5. Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 2011;47:2422-30.
6. Kapoor S. Obesity and the risk for non-Hodgkin lymphoma. Int J Cancer 2008;123:490. (Pubitemid 351842038)
7. Larsson SC, Wolk A. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer 2007;121:1564-70. (Pubitemid 47328717)
8. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008;122:2062-70. (Pubitemid 351441197)
9. Kabat GC, Kim MY, Jean Wactawski W, Bea JW, Edlefsen KL, Adams- Campbell LL, et al. Anthropometric factors, physical activity, and risk of non-Hodgkin's lymphoma in the Women's Health Initiative. Cancer Epidemiol 2012;36:52-9.
10. Maskarinec G, Erber E, Gill J, Cozen W, Kolonel LN. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2008;17:196-203. (Pubitemid 351196291)
11. Lu Y, Prescott J, Sullivan-Halley J, Henderson KD, Ma H, Chang ET, et al. Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am J Epidemiol 2009;170:1231-40.
12. Troy JD, Hartge P, Weissfeld JL, Oken MM, Colditz GA, Mechanic LE, et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 2010;171:1270-81.
13. Kanda J, Matsuo K, Suzuki T, Hosono S, Ito H, Ichinohe T, et al. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer 2010;126:2416-25.
14. Zhang S, Hunter DJ, Rosner BA, Colditz GA, Fuchs CS, Speizer FE, et al. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 1999;91:1751-8. (Pubitemid 29518771)
15. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer (IARC) Press; 2008.
16. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990;1:466-73.
17. Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 1995;19:570-2.
18. Stunkard A, Soernensen T, Schulsinger F. Use of the Danish Adoption Register for the study of obesity and thinness. In: Kety S, Rowland L, Sideman S, Mathysee S, editors. Genetics of neurological and psychiatric disorders. New York: Raven Press; 1983. p. 115-20.
19. Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol 1993;138:56-64. (Pubitemid 23226335)
20. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol Biomarkers Prev 2005;14:925-33. (Pubitemid 40478558)
21. Pan SY, Mao Y, Ugnat AM. Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol 2005;162:1162-73. (Pubitemid 41785910)
22. Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006;163:1053-64. (Pubitemid 43987598)
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
24. Anderson TW. Introduction to multivariate statistics. 2nd ed. NewYork: John Wiley & Sons; 1984.
25. Britton JA, Khan AE, Rohrmann S, Becker N, Linseisen J, Nieters A, et al. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 2008;93:1666-77.
26. Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, et al. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007;166:697-708. (Pubitemid 47347893)
27. Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002;156:527-35. (Pubitemid 35001195)
28. Pylypchuk RD, Schouten LJ, Goldbohm RA, Schouten HC, van den Brandt PA. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol 2009;170:297-307.
29. Engeland A, Tretli S, Hansen S, Bjorge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 2007;165:44-52. (Pubitemid 46026208)
30. Cerhan JR, Bernstein L, Severson RK, Davis S, Colt JS, Blair A, et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control 2005;16:1203-14. (Pubitemid 46187570)
31. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011;12:785-94.
32. Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J. Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 2006;91:2514-9. (Pubitemid 44024611)
33. Wadsworth ME, Hardy RJ, Paul AA, Marshall SF, Cole TJ. Leg and trunk length at 43 years in relation to childhood health, diet and family circumstances; evidence from the 1946 national birth cohort. Int J Epidemiol 2002;31:383-90. (Pubitemid 34537796)
34. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, et al. Obesity, energy balance and cancer: new opportunities for prevention. Cancer Prev Res 2012;5: 1260-72.
35. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
36. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1-16.
37. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev 2001;2:131-40. (Pubitemid 33755922)
38. Ong K, Kratzsch J, Kiess W, Dunger D. Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002;87:1041-4. (Pubitemid 36121062)
39. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915-28.
40. Gibson LF, Piktel D, Landreth KS. Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-Bcells. Blood 1993;82:3005-11. (Pubitemid 23334926)
41. Poole EM, Tworoger SS, Hankinson SE, Schernhammer ES, Pollak MN, Baer HJ. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol 2011;174:642-51.
42. Willett EV, Skibola CF, Adamson P, Skibola DR, Morgan GJ, Smith MT, et al. Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 2005;93:811-6. (Pubitemid 41486443)
43. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:779-86. (Pubitemid 38737867)
44. Aschebrook-Kilfoy B, Ollberding NJ, Kolar C, Lawson TA, Smith SM, Weisenburger DD, et al. Meat intake and risk of non-Hodgkin lymphoma. Cancer Causes Control 2012;23:1681-92.
45. Chiu BC, Kwon S, Evens AM, Surawicz T, Smith SM, Weisenburger DD. Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma. Cancer Causes Control 2011;22:1183-95.
46. Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008;112:5150-60.
47. Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet 2011;7:e1001378.
48. Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007;67:5042-54. (Pubitemid 46910215)
49. Chang CM, Wang SS, Dave BJ, Jain S, Vasef MA, Weisenburger DD, et al. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer 2011;129:938-47.
50. Chiu BC, Lan Q, Dave BJ, Blair A, Zahm SH, Weisenburger DD. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr 2008;69-73.